医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Global Virus Network on H7N9 Bird Flu Outbreak

2013年04月20日 AM02:10
このエントリーをはてなブックマークに追加


 

BALTIMORE

As of April 19, 2013, mainland China reported 87 cases of human infection of a new strain of bird influenza, A(H7N9), including 17 deaths. Thus far, the cases are sporadic and have no evidence of human-to-human transmission. According to the Global Virus Network’s Dr. Peter Palese of the Icahn School of Medicine at Mount Sinai, “It is important to note that sporadic human infections with H7 viruses have occurred in the past – this is not a unique situation.”

Dr. Sharon Hrynkow, President of the Global Virus Network (GVN) stated that GVN scientists from China, Japan and the US were sharing data and information in order to assist with efforts to address this outbreak. “The coalition of scientists comprising the Global Virus Network have pledged to work together in outbreak situations as a way to speed knowledge about risk factors, severity of disease and development of interventions. This situation is an example of how the GVN adds value in addressing critical health challenges.”

GVN’s Dr. Yuelong Shu, who is Deputy Director of National Institute for Viral Disease Control and Prevention, China CDC, said, “We will continue to prioritize the public’s health and security and adhere to the requirements of the International Health Regulations (2005) to maintain transparency.”

Dr. Robert Gallo, Co-Founder and Scientific Director of the GVN, lauded China for “the swiftness with which it responded to the epidemic, released information in a timely manner and cooperated with international organizations.”

As we have viral genome sequences of H7N9, GVN is working with Chinese colleagues to obtain information about the pathogenesis of some of the most severe cases from a postmortem examination of fatal cases to better understand the disease. GVN’s Hideki Hasegawa of the National Institutes of Infectious Diseases in Tokyo says, “Some drug resistant mutation was reported, so we would like to know the clinical outcome of the treatment. Additionally, we would like to hear from China about risk factors (age, sex, underlying conditions, etc.) of the severity of the disease which would also help for preparation of vaccine policy.” GVN’s Andrew Pekosz of the Johns Hopkins Bloomberg School of Public Health says we need “to continue rigorous epidemiological studies to detect potential for human-to-human transmission.”

Dr. Shu continued, “GVN’s China-CDC is committed to working with the GVN colleagues to identify the disease etiology characteristics of H7N9 and its epidemic features. We will also work with GVN Centers to collect and analyze domestic and foreign related research progress and results, conduct dynamic risk assessment, and develop prevention control strategies and measures that are driven by the science.”

Frequently Asked Questions on human infection with influenza A(H7N9) virus, China

About Global Virus Network (GVN)

The Global Virus Network (GVN) is a non-profit, 501(C)(3) organization, comprised of leading medical virologists from Argentina, Australia, Belgium, Canada, China, France, Germany, India, Ireland, Israel, Italy, Japan, Netherlands, Russia, South Africa, Spain, Sweden, the United Kingdom and the United States of America. The GVN’s mission is to combat emerging pandemic viral threats through international collaborative research, training the next generation of medical virologists, and advocacy. For more information, please contact Nora Grannell at ngrannell@gvn.org.

CONTACT

Global Virus Network (GVN)
Nora Grannell, 410-706-1966
ngrannell@gvn.org

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings
  • Cerveau Technologies, Inc.与日本东京都老人综合研究所签订研究协议
  • 继美国和英国之后,中国向Personalis, Inc.签发ACE©技术专利,扩大了其在国际上的知名度
  • セルヴォー・テクノロジーズが日本の東京都健康長寿医療センター研究所と研究契約を締結
  • 国際的な食品・飲料企業の連合が、世界の供給食料から人工トランス脂肪酸を排除するための世界保健機関とResolve to Save Livesによる呼び掛けを支持